Rebecca Wolverton
Family · Fort Worth, TXNPI 1063870087
Payments from drug & device makers
Across 99 payments — averaging $18.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$180
- Sumitomo Pharma America, Inc.$179
- AbbVie$166
- Novo Nordisk$166
- Lilly USA, LLC$137
- Novartis$86
- plus $944 from 26 others
What the payments were for
- Food & beverage$1,859100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 6 | $180 |
| Sumitomo Pharma America, Inc. | 11 | $179 |
| AbbVie | 7 | $166 |
| Novo Nordisk | 9 | $166 |
| Lilly USA, LLC | 8 | $137 |
| Novartis | 4 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $82 |
| Mylan Specialty L.p. | 4 | $80 |
| AstraZeneca | 5 | $75 |
| Amgen | 4 | $65 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $52 |
| Astellas Pharma US Inc | 3 | $51 |
| Bayer | 3 | $50 |
| Pfizer | 3 | $50 |
| Amarin Pharma, Inc. | 3 | $40 |
| Viatris Specialty LLC | 2 | $39 |
| Boehringer Ingelheim | 2 | $36 |
| Merck | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Abbott | 1 | $27 |
| Upsher-smith Laboratories LLC | 2 | $26 |
| Almatica Pharma LLC | 1 | $24 |
| Lundbeck LLC | 1 | $23 |
| Azurity Pharmaceuticals, Inc. | 1 | $23 |
| Pharmacosmos Therapeutics Inc. | 1 | $22 |
| Antares Pharma, Inc. | 1 | $21 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Vivus LLC | 1 | $15 |
| Althera Pharmaceuticals LLC | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SHINGRIX$114
How this compares
$1,859 in reported general payments places this provider in the 80th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 54 | $70,291 |
| EliquisApixaban | 44 | $28,366 |
| JardianceEmpagliflozin | 13 | $7,955 |
| SymbicortBudesonide/Formoterol Fumarate | 14 | $5,822 |
| Gabapentin | 65 | $1,435 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 50 | $1,426 |
| Duloxetine Hcl | 68 | $1,094 |
| Boostrix TdapDiphth,pertuss(Acell),tet Vac | 15 | $1,046 |
| Tramadol Hcl | 89 | $894 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 41 | $810 |
| Atorvastatin Calcium | 62 | $643 |
| Ropinirole Hcl | 12 | $598 |
| Rosuvastatin Calcium | 29 | $585 |
| Montelukast Sodium | 76 | $533 |
| Estradiol | 11 | $533 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $166 | $70,29154 claims |
| PfizerEliquis | $50 | $28,36644 claims |
| Boehringer IngelheimJardiance | $36 | $7,95513 claims |
| AstraZenecaSymbicort | $75 | $5,82214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 15,456 family providers in Texas.
Other family in Fort Worth
- Laura MoeFort Worth$158K
- Julie TaylorFort Worth$63K
- Ryan BourgeoisFort Worth$37K
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.